Adaptimmune Therapeutics (ADAP) Institutional Ownership → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free ADAP Stock Alerts $1.20 -0.04 (-3.23%) (As of 05/16/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Adaptimmune Therapeutics (NASDAQ:ADAP)CurrentInstitutional OwnershipPercentage31.37%Number ofInstitutional Buyers(last 12 months)18TotalInstitutional Inflows(last 12 months)$8.27MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$1.68M Get ADAP Insider Trade Alerts Want to know when executives and insiders are buying or selling Adaptimmune Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ADAP Institutional Buying and Selling by Quarter Ad Crypto 101 MediaShocking $16T Elon Musk Crypto LeakThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay attention to above all others: Venture capital firms. You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening.Click here for all the details… Adaptimmune Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/15/2024 Baker BROS. Advisors LP10,787,022$17.04M0.2%-1.7%4.370% 5/14/2024 Boulder Hill Capital Management LP90,800$143K0.1%N/A0.037% 5/3/2024 GSA Capital Partners LLP370,179$585K0.0%-27.2%0.150% 5/1/2024 Baillie Gifford & Co.15,871,875$25.08M0.0%-0.3%6.431% 4/19/2024 JTC Employer Solutions Trustee Ltd26,156$41K0.0%N/A0.003% 4/15/2024 Key Client Fiduciary Advisors LLC268,655$424K0.2%-20.2%0.027% Get the Latest News and Ratings for ADAP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Adaptimmune Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 4/15/2024 Columbia Advisory Partners LLC15,585$25K0.0%N/A0.002% 3/5/2024 Twin Focus Capital Partners LLC55,526$44K0.0%N/A0.006% 1/26/2024 Baillie Gifford & Co.15,912,140$12.62M0.0%-7.2%1.600% 1/9/2024 Key Client Fiduciary Advisors LLC336,620$267K0.2%+6.4%0.034% 1/8/2024 Harbor Capital Advisors Inc.147,732$117K0.0%+9.9%0.015% 11/13/2023 Baillie Gifford & Co.17,147,409$13.38M0.0%-0.2%1.725% 10/27/2023 Marquette Asset Management LLC99,349$77K0.0%N/A0.010% 10/27/2023 Acuitas Investments LLC479,764$374K0.2%N/A0.048% 10/20/2023 Harbor Capital Advisors Inc.134,415$105K0.0%+19.5%0.014% 9/21/2023 Barclays PLC50,061$46K0.0%N/A0.005% 9/7/2023 MPM Asset Management LLC6,287,101$5.82M2.9%N/A0.632% 8/15/2023 Black Maple Capital Management LP69,839$65K0.0%N/A0.007% 8/14/2023 X Square Capital LLC26,771$25K0.0%N/A0.003% 8/14/2023 CSS LLC IL90,702$84K0.0%N/A0.009% 8/11/2023 Artal Group S.A.1,133,775$1.05M0.0%N/A0.114% 8/7/2023 Acadian Asset Management LLC358,010$329K0.0%+15.1%0.036% 8/3/2023 Oppenheimer & Co. Inc.68,171$63K0.0%N/A0.007% 7/28/2023 Baillie Gifford & Co.17,176,135$15.89M0.0%+0.4%1.728% 7/11/2023 Harbor Capital Advisors Inc.112,516$104K0.0%N/A0.073% 5/17/2023 Long Focus Capital Management LLC5,435,439$5.93M0.3%+2.9%3.514% 5/12/2023 Long Focus Capital Management LLC2,772,791$3.02M0.3%-47.5%1.793% 5/10/2023 Simplify Asset Management Inc.150,000$164K0.0%N/A0.097% 5/3/2023 Baillie Gifford & Co.17,112,002$18.65M0.0%-0.3%11.064% 5/1/2023Virtu Financial LLC88,234$96K0.0%+193.1%0.057% 4/25/2023 Key Client Fiduciary Advisors LLC321,155$350K0.2%+8.2%0.208% 2/15/2023 Endurant Capital Management LP1,733,236$2.53M1.0%-3.1%1.058% 2/14/2023Susquehanna International Group LLP28,126$41K0.0%N/A0.017% 2/9/2023 HBK Sorce Advisory LLC70,000$65K0.0%+100.0%0.043% 1/17/2023 Key Client Fiduciary Advisors LLC296,740$433K0.3%-31.9%0.181% 1/11/2023 Vigilare Wealth Management28,800$42K0.0%-21.7%0.018% 11/15/2022 PFM Health Sciences LP9,320,584$10.02M0.4%+2.3%5.689% 11/15/2022 Long Focus Capital Management LLC4,789,490$5.15M0.5%+2.4%2.923% 11/15/2022 Endurant Capital Management LP1,788,517$1.92M0.6%-1.9%1.092% 11/14/2022 HBK Sorce Advisory LLC35,000$32K0.0%N/A0.021% Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy.11/10/2022 ExodusPoint Capital Management LP370,288$398K0.0%+23.4%0.227% 11/7/2022Virtu Financial LLC40,503$44K0.0%+133.7%0.025% 11/3/2022 Barclays PLC340,068$366K0.0%+34.6%0.208% 10/27/2022 Baillie Gifford & Co.14,664,936$15.76M0.0%-4.3%8.977% 10/12/2022 Key Client Fiduciary Advisors LLC435,985$469K0.4%+4.8%0.267% 8/12/2022 Rafferty Asset Management LLC217,123$369K0.0%-59.5%0.134% 8/11/2022 Alps Advisors Inc.96,110$163K0.0%N/A0.059% 8/10/2022 Hunter Associates Investment Management LLC28,500$49K0.0%+42.5%0.018% 8/8/2022 Baillie Gifford & Co.15,321,346$26.05M0.0%-0.4%9.457% 7/11/2022 Vigilare Wealth Management41,800$71K0.1%N/A0.026% 5/17/2022 Endurant Capital Management LP2,160,890$4.45M1.2%+140.7%1.335% 5/16/2022 Eversept Partners LP237,086$488K0.0%-32.0%0.151% 5/11/2022 GSA Capital Partners LLP69,612$143K0.0%-17.3%0.044% 5/5/2022 Baillie Gifford & Co.15,380,538$31.68M0.0%+11.8%9.805% 5/5/2022 Levy Wealth Management Group LLC17,590$36K0.0%N/A0.011% 4/29/2022 Daiwa Securities Group Inc.35,516$73K0.0%+44.9%0.023% 4/26/2022 Hunter Associates Investment Management LLC20,000$41K0.0%+81.8%0.013% 4/21/2022 Inspire Investing LLC31,928$66K0.0%+107.4%0.020% 4/21/2022 Inspire Advisors LLC45,105$93K0.0%+193.0%0.029% 4/18/2022 Key Client Fiduciary Advisors LLC420,447$866K0.7%+58.0%0.268% 2/14/2022 Long Focus Capital Management LLC2,162,313$8.11M1.1%N/A1.384% 2/14/2022 Point72 Asset Management L.P.565,208$2.12M0.0%+640.8%0.362% 2/14/2022 DAFNA Capital Management LLC136,266$511K0.1%N/A0.087% 2/14/2022 Eversept Partners LP348,716$1.31M0.1%-21.6%0.223% 2/14/2022 GSA Capital Partners LLP84,129$315K0.0%-82.6%0.054% 2/11/2022 Syncona Portfolio Ltd1,377,294$5.17M4.9%N/A0.882% 2/10/2022 Rafferty Asset Management LLC606,763$2.28M0.0%-18.1%0.388% 2/8/2022 Bank of America Corp DE538,111$2.02M0.0%-26.5%0.344% 2/8/2022 ProShare Advisors LLC19,315$72K0.0%-34.0%0.012% 2/7/2022 Mitsubishi UFJ Kokusai Asset Management Co. Ltd.69,140$281K0.0%+13.6%0.044% 2/3/2022 Daiwa Securities Group Inc.24,515$92K0.0%+59.4%0.016% 2/3/2022 Inspire Investing LLC15,393$58K0.0%N/A0.010% 1/27/2022 Hunter Associates Investment Management LLC11,000$41K0.0%N/A0.007% 1/20/2022 Baillie Gifford & Co.13,756,352$51.59M0.0%+7.3%8.807% 12/1/2021 Balyasny Asset Management LLC259,413$1.34M0.0%N/A0.166% 11/18/2021 Personal CFO Solutions LLC36,388$188K0.0%+19.7%0.023% 11/16/2021 Schonfeld Strategic Advisors LLC349,683$1.81M0.0%-1.7%0.224% 11/16/2021ACT Capital L.L.C.90,000$465K0.2%N/A0.058% 11/16/2021 Squarepoint Ops LLC31,881$165K0.0%+127.8%0.020% 11/16/2021Toroso Investments LLC10,554$55K0.0%N/A0.007% 11/16/2021 Millennium Management LLC1,584,849$8.19M0.0%+70.3%1.015% 11/15/2021 Point72 Asset Management L.P.76,300$394K0.0%-96.3%0.049% 11/15/2021 Cubist Systematic Strategies LLC57,953$300K0.0%+485.4%0.037% 11/15/2021 Man Group plc148,305$767K0.0%+44.2%0.095% 11/15/2021 Tudor Investment Corp Et Al16,004$83K0.0%N/A0.010% 11/15/2021 Rock Springs Capital Management LP2,189,788$11.32M0.2%+41.7%1.403% 11/15/2021 Marshall Wace LLP1,553,800$8.03M0.0%N/A0.995% 11/15/2021 Balyasny Asset Management LLC259,413$1.34M0.0%N/A0.166% 11/15/2021 Wealthspire Advisors LLC11,750$61K0.0%N/A0.008% 11/15/2021 Virtus ETF Advisers LLC47,350$245K0.1%-5.0%0.030% Obama’s Forever Term [exposed] (Ad)America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.Start streaming it now at no cost here11/15/2021 Eversept Partners LP444,887$2.30M0.2%N/A0.285% 11/15/2021 GSA Capital Partners LLP484,782$2.51M0.3%-5.6%0.311% 11/12/2021 Trexquant Investment LP23,609$122K0.0%N/A0.015% 11/12/2021 Blueshift Asset Management LLC11,933$62K0.0%N/A0.008% 11/10/2021 US Bancorp DE5,729$29K0.0%+403.0%0.004% 11/10/2021 Goldman Sachs Group Inc.330,378$1.71M0.0%-13.3%0.212% 11/10/2021 KBC Group NV45,900$237K0.0%+77.2%0.029% 11/10/2021 Citigroup Inc.41,991$217K0.0%-15.9%0.027% 11/10/2021 Rafferty Asset Management LLC740,915$3.83M0.0%-9.5%0.475% 11/10/2021 Healthcare of Ontario Pension Plan Trust Fund60,300$312K0.0%-94.1%0.039% (Data available from 1/1/2016 forward) ADAP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ADAP shares? During the previous two years, 32 institutional investors and hedge funds held shares of Adaptimmune Therapeutics. The most heavily invested institutionals were Baillie Gifford & Co. ($25.08M), Baker BROS. Advisors LP ($17.04M), PFM Health Sciences LP ($10.02M), Long Focus Capital Management LLC ($5.93M), MPM Asset Management LLC ($5.82M), Endurant Capital Management LP ($2.53M), and Artal Group S.A. ($1.05M).Learn more on ADAP's institutional investors. What percentage of Adaptimmune Therapeutics stock is owned by institutional investors? 31.37% of Adaptimmune Therapeutics stock is owned by institutional investors. Learn more on ADAP's institutional investor holdings. Which institutional investors have been buying Adaptimmune Therapeutics stock? Of the 28 institutional investors that purchased Adaptimmune Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: MPM Asset Management LLC ($6.29M), Endurant Capital Management LP ($1.26M), Artal Group S.A. ($1.13M), Acuitas Investments LLC ($479.76K), Long Focus Capital Management LLC ($261.80K), PFM Health Sciences LP ($210.80K), and Simplify Asset Management Inc. ($150K). How much institutional buying is happening at Adaptimmune Therapeutics? Institutional investors have bought a total of 11,186,509 shares in the last 24 months. This purchase volume represents approximately $12.06M in transactions. Which Adaptimmune Therapeutics major shareholders have been selling company stock? Of the 9 institutional investors that sold Adaptimmune Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Long Focus Capital Management LLC ($2.51M), Baillie Gifford & Co. ($2.08M), Rafferty Asset Management LLC ($318.99K), Key Client Fiduciary Advisors LLC ($207.21K), Baker BROS. Advisors LP ($182.26K), GSA Capital Partners LLP ($138.63K), and Eversept Partners LP ($111.63K). How much institutional selling is happening at Adaptimmune Therapeutics? Institutional investors have sold a total of 5,646,196 shares in the last 24 months. This volume of shares sold represents approximately $6.39M in transactions. Related Companies: STRO Major Shareholders CADL Major Shareholders PSTX Major Shareholders GLUE Major Shareholders FENC Major Shareholders CHRS Major Shareholders IVVD Major Shareholders AGEN Major Shareholders MGX Major Shareholders CMPX Major Shareholders This page (NASDAQ:ADAP) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersCharles Payne Demystifies OptionsUnstoppable ProsperityGold Set to EXPLODE!Gold Safe ExchangeBiden FINISHED On June 13th?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingHow Biden has already won 2024Porter & CompanyWhy Is Gold On a MASSIVE rally? Huge AlertsProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adaptimmune Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.